Difference between revisions of "PET Amyloid Biomarker Ctte"

From QIBA Wiki
Jump to navigation Jump to search
 
(63 intermediate revisions by 2 users not shown)
Line 1: Line 1:
 
:Co-chairs: Satoshi Minoshima, MD, PhD; Anne M. Smith, PhD; Dawn C. Matthews, MS, MBA
 
:Co-chairs: Satoshi Minoshima, MD, PhD; Anne M. Smith, PhD; Dawn C. Matthews, MS, MBA
  
:Secretary: Julie Lisiecki
+
:RSNA Staff Support: Julie Lisiecki
 
* [http://tinyurl.com/QIBA-PET-Amyloid-Roster Roster]
 
* [http://tinyurl.com/QIBA-PET-Amyloid-Roster Roster]
  
Line 20: Line 20:
 
==PET Amyloid Meetings/Call Summaries==
 
==PET Amyloid Meetings/Call Summaries==
  
*[[Media:04_13_2018_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL.pdf|04.13.2018 QIBA PET Amyloid Biomarker Committee Call Summary]]
+
*[[Media:2022_05-20_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL-DM-AMS.pdf|May 20, 2022]]
*[[Media:03_09_2018_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL.pdf|03.09.2018 QIBA PET Amyloid Biomarker Committee Call Summary]]
+
*[[Media:2022_04-15_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|April 15, 2022]]
*[[Media:02_09_2018_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL-dcm.pdf|02.09.2018 QIBA PET Amyloid Biomarker Committee Call Summary]]
+
*[[Media:2022_03-11_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|March 11, 2022]]
*[[Media:01_12_2018_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL-dcm.pdf|01.12.2018 QIBA PET Amyloid Biomarker Committee Call Summary]]
+
*[[Media:2022_02-11_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|February 11, 2022]]
*[[Media:10_13_2017_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL.pdf|10.13.2017 QIBA PET Amyloid Biomarker Committee Call Summary]]
+
*[[Media:2022_01-14_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|January 14, 2022]]
*[[Media:09_08_2017_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL.pdf|09.08.2017 QIBA PET Amyloid Biomarker Committee Call Summary]]
+
 
*[[Media:08_11_2017_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL.pdf|08.11.2017 QIBA PET Amyloid Biomarker Committee Call Summary]]
 
  
 
'''''[[PET Amyloid BC Call Summaries Archive]]'''''
 
'''''[[PET Amyloid BC Call Summaries Archive]]'''''
  
 
==PET Amyloid Profile Development==
 
==PET Amyloid Profile Development==
 +
 +
Clean version of Technically Confirmed Profile for use! - also available on the Profiles {https://qibawiki.rsna.org/index.php/Profiles} page
 +
*[[Media:Supplement_QIBA_AmyloidPET_3Jun2022_TechnicallyConfirmed.pdf | 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker-2022-06-03]] clean version
 +
 +
---------------------------------------------------------
 +
Redlined version of Technically Confirmed Profile - showing comments addressed:
 +
*[[Media:QIBA_AmyloidPET_1Jun2022_TechnicallyConfirmed edits redlined.pdf | 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker-2022-06-01]] edits redlined
 +
 +
---------------------------------------------------------
 +
For NM CC vote - Technically Confirmed:
 +
 +
*[[Media:QIBA_PET Amyloid_Profile_14April2022-per-public-comment-clean.pdf | 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker(clean version)-2022-04-14]]
 +
*[[Media:QIBA_PET Amyloid_Profile_14April2022-per-public-comment-redline.pdf | 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker(marked up version)-2022-04-14]]
 +
*[[Media:QIBA_PET Amyloid_Profile_Updates_15April2022.pdf | Profile Updates Summary-2022-04-15]]
 +
----------------------------------------------------------
 +
*[[Media:QIBA AmyloidPET 20June2018 consensus.pdf| PET F-18 for Amyloid 2018-06-20]] - Consensus Profile
  
 
*[[Media:QIBA_PET Amyloid_Profile_15June2017-post-public-comment.pdf | 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker - 2018-05-02]]  
 
*[[Media:QIBA_PET Amyloid_Profile_15June2017-post-public-comment.pdf | 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker - 2018-05-02]]  
 
 
**[[Media:QIBA_PET Amyloid_Profile_02May2018-public-comments-and-responses.pdf | QIBA Public Comments and Responses - 2018-05-02]]  
 
**[[Media:QIBA_PET Amyloid_Profile_02May2018-public-comments-and-responses.pdf | QIBA Public Comments and Responses - 2018-05-02]]  
  
 
*[[Media:QIBA_AmyloidPET_15June2017.pdf| QIBA PET Amyloid Profile 2017-06-15]] (''Closed on September 15, 2017'')  
 
*[[Media:QIBA_AmyloidPET_15June2017.pdf| QIBA PET Amyloid Profile 2017-06-15]] (''Closed on September 15, 2017'')  
 +
**[[Media:QIBA_PET_Amyloid_Profile_15June2017_edited_per_public_comment_rl.pdf | QIBA PET-Amyloid DRAFT Profile with tracked changes - 2017-06-15]]
  
 
* [[Media:QIBA PET Amyloid Profilea.pdf| QIBA PET Amyloid Profile 2017-04-28]] (BC Vote to Release for Public Comment Form:  https://goo.gl/forms/0RqF8V6HlXlUNi903)  
 
* [[Media:QIBA PET Amyloid Profilea.pdf| QIBA PET Amyloid Profile 2017-04-28]] (BC Vote to Release for Public Comment Form:  https://goo.gl/forms/0RqF8V6HlXlUNi903)  
Line 59: Line 74:
 
==Presentations and Reports==
 
==Presentations and Reports==
  
 +
*[[Media:08Jun2018_BCMeeting_Amyloid_updated.pdf | 06 08 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews]]
 +
*[[Media:11May2018_BCMeeting_Amyloid_updated.pdf | 05 11 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews]]
 +
*[[Media:13April2018_BCMeeting_Amyloid.pdf | 04 13 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews]]
 +
*[[Media:09March2018_BCMeeting_Amyloid.pdf | 03 09 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews]]
 +
 +
*[[Media:09Feb2018_BCMeeting_Amyloid.pdf | 02 09 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews]]
 
*[[Media:12Jan2018_BCMeeting_Amyloid.pdf | 01 12 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Dr. Smith]]
 
*[[Media:12Jan2018_BCMeeting_Amyloid.pdf | 01 12 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Dr. Smith]]
 
*[[Media:QIBA-ADNI Amyloid Data Acquisition Gap Analysis v1.pdf | 01 12 2018 QIBA PET Amyloid Profile / ADNI Gap Analysis - presented by Ms. Matthews]]
 
*[[Media:QIBA-ADNI Amyloid Data Acquisition Gap Analysis v1.pdf | 01 12 2018 QIBA PET Amyloid Profile / ADNI Gap Analysis - presented by Ms. Matthews]]
 +
 +
*[[Media:12Oct2017_BCMeeting_Amyloid.pdf | 10 12 2017 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews]]
  
 
*[[Media:QIBAPETAmyloid_IAW_Conformance-9-9-2016.pdf | 09 09 2016 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Dr. Smith]]
 
*[[Media:QIBAPETAmyloid_IAW_Conformance-9-9-2016.pdf | 09 09 2016 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Dr. Smith]]
Line 72: Line 95:
  
 
*[[Media:02 13 2015 QIBA PET Amyloid Biomarker Committee Presentation Notes.pdf|02 13 2015 QIBA PET Amyloid Biomarker Committee Presentation Notes - presented by Dr. Perlman]]
 
*[[Media:02 13 2015 QIBA PET Amyloid Biomarker Committee Presentation Notes.pdf|02 13 2015 QIBA PET Amyloid Biomarker Committee Presentation Notes - presented by Dr. Perlman]]
 +
 +
==QIBA Funded Projects==
 +
 +
====Round 4====
 +
*[[Media:Amyloid Profile Continued Support with Brain Phantom Development.pdf | Project (X) Amyloid Profile Continued Support with Brain Phantom Development (University of Iowa)]]
 +
 +
====Round 5====
 +
*[[Media:Analyses to Support Amyloid Imaging Profile Development.pdf | Project (A) Analyses to Support Amyloid Imaging Profile Development (ADM Diagnostics, LLC)]]
 +
 +
*[[Media:Amyloid Brain PET Test-Retest Meta-analysis.pdf | Project (E) Amyloid Brain PET Test-Retest Meta-analysis (Johns Hopkins University)]]
 +
 +
*[[Media:A PET-Metabolic Tumor Volume-DRO.pdf | Project (I) A PET-Metabolic Tumor Volume-Digital Reference Object (PET-MTV-DRO) (University of Washington)]]
 +
 +
*[[Media:A Procedure to Facilitate Greater Standardization of PET Spatial Resolution.pdf | Project (J) A Procedure to Facilitate Greater Standardization of PET Spatial Resolution (Johns Hopkins University)]]

Latest revision as of 23:18, 3 June 2022

Co-chairs: Satoshi Minoshima, MD, PhD; Anne M. Smith, PhD; Dawn C. Matthews, MS, MBA
RSNA Staff Support: Julie Lisiecki


Project Snapshot

There is a draft Profile, and current outline of the Claim is:

  • SUVr will be the measurand
  • The claim will have two components
1) Cross-sectional: single subject scan
2) Longitudinal: following subject over time

Due to the complexity of having multiple PET Amyloid tracers, a subgroup, the Test-retest Group, has been formed including academics and industry representatives from all of the major PET Amyloid tracer vendors. This group will evaluate the published data on amyloid imaging precision, to determine what level of precision can be claimed in the Profile. The committee’s goal is to have a final draft Profile by December, 2015.

Collaborations: RSNA QIBA is now an affiliate of GAAIN (Global Alzheimer’s Association International Network)

PET Amyloid Meetings/Call Summaries


PET Amyloid BC Call Summaries Archive

PET Amyloid Profile Development

Clean version of Technically Confirmed Profile for use! - also available on the Profiles {https://qibawiki.rsna.org/index.php/Profiles} page


Redlined version of Technically Confirmed Profile - showing comments addressed:


For NM CC vote - Technically Confirmed:


Profile Supporting Material

Working Documents

Presentations and Reports

QIBA Funded Projects

Round 4

Round 5